ReviewTherapeutic advances in respiratory disease

The once-daily fixed-dose combination of olodaterol and tiotropium in the management of COPD: current evidence and future prospects.

Eric Derom et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.